VLS-732

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameVLS-732
Drug Alias NameCVVS-732VLS-732
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValneva SE
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValneva SE
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A